23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.
23andMe was founded in 2006 by Anne Wojcicki, Linda Avey, Paul Cusenza.
23andMe's investment strategy appears to focus on companies that are innovating in sectors related to health care and education, with a particular interest in technology-driven solutions. The investments span across different regions, including both the United States and the United Kingdom, indicating a willingness to invest in companies regardless of their geographic location, as long as they align with the strategic interests of the company. The presence of software and apps in the industries and industry groups suggests a preference for platforms that can scale and potentially integrate with 23andMe's core business of genetic data. The strategy seems to be non-leading in terms of investment rounds, as they have not taken the lead in the investments listed, which may suggest a collaborative approach to funding, working alongside other investors. Companies that might attract 23andMe for future investments would likely be those at the intersection of biotechnology and information technology, especially those that leverage data analytics and software to innovate in personalized health care, genetic research, or educational platforms that can enhance understanding of human genetics.
1282 health care and life sciences companies are in the directory, 61 of them in the same 501-1,000 employee range and 43 based in San Francisco Bay Area.
“23andMe offers DNA testing with the most comprehensive ancestry breakdown, personalized health insights and more.” 23andme.com
23andMe is a biotechnology company based in San Francisco Bay Area, with 501-1,000 employees, founded in 2006. Its founders are Anne Wojcicki, Linda Avey and Paul Cusenza and it has raised $1.1 billion over 14 rounds.
11-50 employees · acernatec.com
11-50 employees · adm-labs.com
501-1,000 employees · abzena.com
501-1,000 employees · apcerls.com
251-500 employees · actgenomics.com
1,001-5,000 employees · 3acomposites.com
1,001-5,000 employees · add.life
101-250 employees · 4dmoleculartherapeutics.com
11-50 employees · alxoncology.com
11-50 employees · advansta.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.